50% of women who stop menopausal hormone therapy will have recurrence of their symptoms and 50% won't.
Kumyinge wama-50% wamabhinqa ayekayo ukufumana unyango lweehomoni lwesigaba sokuyeka ukuya exesheni ziyabuya iimpawu zawo ukanti kumyinge wama-50% azibuyi.